Serum Source International, Inc. v. GE Healthcare Bio-Sciences Corp. et al
Filing
51
ORDER denying 49 Motion to Stay. The court OVERRULES Defendant's objections in part and SUSTAINS in part, and AFFIRMS the Magistrate's Orders in part and MODIFIES in part. The parties are hereby ORDERED to comply with the Magistrate's March 8, 2017, and March 10, 2017 Decisions. Signed by Chief Judge Frank D. Whitney on 3/22/17. (mga)
UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF NORTH CAROLINA
CHARLOTTE DIVISION
DOCKET NO. 3:16-CV-00471-FDW-DLH
SERUM SOURCE INTERNATIONAL,
INC.,
Plaintiff,
vs.
GE HEALTHCARE BIO-SCIENCES
CORP.,
Defendant.
)
)
)
)
)
)
)
)
)
)
)
)
ORDER
THIS MATTER is before the Court on Defendant’s Objection to the Magistrate Judge’s
March 8, 2017 Decision granting Plaintiff’s Motion to Compel in part (Doc. No. 47), Defendant’s
Objection to the Magistrate Judge’s March 10, 2017 Decision ordering Defendant submit an
allegedly privileged internal report for in camera review (Doc. No. 48), and Defendant’s Consent
Motion to Stay Discovery (Doc. No. 49). In short, Defendant contends the Magistrate’s March 8,
2017 Decision (Doc. No. 39) fails to consider cost proportionality or the relevancy of Plaintiff’s
discovery requests, and the Magistrate’s March 10, 2017 Decision (Doc. No. 42) was unsupported
by any factual or legal basis that allowed the Court to order in camera review.
After hearing the parties arguments at a March 21, 2017, teleconference with the Court,
and for the reasons set forth at the teleconference and contained within the Magistrate’s Orders,
the Court DENIES Defendant’s Motion to Stay (Doc. No. 49), OVERRULES Defendant’s
objections in part and SUSTAINS in part, and AFFIRMS the Magistrate’s Orders in part and
MODIFIES in part. The parties are hereby ORDERED to comply with the Magistrate’s March 8,
2017, and March 10, 2017 Decisions with the following modifications:
1. E-Discovery shall be limited to documentation within the United States only; however,
the Court may revisit international discovery at the parties’ request;
2. All Discovery, including the E-Discovery at issue, is to be completed on or before April
6, 2017;
3. Defendant shall spend up to and including two million dollars to comply with this
Court’s Order, the Magistrate Judge’s Orders (Docs. Nos. 39, 42), and this Court’s
Case Management Order (Doc. No. 18); and the parties shall notify the Court if
additional discovery is necessary after the two million dollar figure is reached;
4. Defendant shall produce the “FDA Recall Report” for Plaintiff by 5:00 p.m. on March
22, 2017;
5. Defendant’s Counsel, Mr. Jon Berkelhammer, shall personally deliver the allegedly
privileged report directly to Chief Judge Frank D. Whitney at 2:00 p.m. at the Charles
R. Jonas Federal Building, 401 W. Trade St., Suite 195, Charlotte, North Carolina
28202; and
6. The parties shall conduct mediation on or before May 4, 2017; however, the Court
encourages an earlier mediation if possible.
SO ORDERED.
Signed: March 22, 2017
2
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?